The National PKU Alliance Research Grants fund innovative science to improve PKU management, develop new treatments, and work toward a cure for phenylketonuria.
Funder: National PKU Alliance
Due Dates (Anticipated): May 2027 (Full application deadline, projected)
Funding Amounts: Typical awards range from $50,000–$100,000 per year; over $6.5 million has been awarded to date across 85+ projects.
Summary: Supports innovative research to improve PKU management, develop new therapies, and advance toward a cure.
Key Information: U.S.-based researchers and institutions are prioritized; check program page for updates on next cycle.
The National PKU Alliance Research Grants program funds pioneering research in phenylketonuria (PKU), a rare metabolic disorder. The program aims to improve disease management, foster the development of new therapeutic options, and ultimately find a cure for PKU. By supporting both basic and translational science, the initiative encourages collaboration among leading researchers, clinicians, and industry partners, and advances innovative approaches that can enhance the quality of life for individuals living with PKU.